Sexually transmitted infection

Gynecological Devices Market is Predicted to Rise at a CAGR of 3.8% during the Forecast Period, observes TMR Study

Retrieved on: 
Thursday, June 30, 2022
Ageing, Breast pain, Pelvic inflammatory disease, Laparoscopy, Vaginal bleeding, Endoscopy, Endometrial cancer, Cancer, Female, PID, Woman, MIS, Vaginal discharge, Human, CAGR, Top 40, Sexually transmitted infection, Incidence, STD, Ovarian cancer, Birth control

The global gynecological devices market estimated to attain valuation of US$ 25,267.43 Mn by 2027.

Key Points: 
  • The global gynecological devices market estimated to attain valuation of US$ 25,267.43 Mn by 2027.
  • Global gynecological devices market growth is anticipated to be fueled by a rise in the occurrences of gynecological illnesses and a rise in patient demand for less invasive treatments.
  • Additionally, the market is expected to grow as healthcare costs rise, recent developments in the gynecological devices and gynecological illnesses become increasinglyunderstood.
  • Rise in STDs are expected to drive future market demand for gynecological devices in the years to come.

Health Advisory: Protecting Yourself and Others from Monkeypox

Retrieved on: 
Tuesday, June 28, 2022
Ill, Fever, Allergy, Sex, Fertility, Virus, COVID, Sexually transmitted infection, STI, COVID-19, Chills, Condom, Infection, Rash, Simplex, Toxicology, CMO, Syphilis, Monkeypox, Risk, Headache, Health status of Asian Americans, Fatigue, Health minister, Signs and symptoms, Myalgia, STD, LOS, Diabetes, CDC, Vaccine, Birth control

LOS ANGELES, June 28, 2022 /PRNewswire/ -- Monkeypox has landed in the United States. Are you at risk? Symptoms outlined by the CDC resemble several common sexually transmitted infections (STI). Similar to STIs, monkeypox can be transmitted through direct contact with bodily fluid or lesions.

Key Points: 
  • Similar to STIs, monkeypox can be transmitted through direct contact with bodily fluid or lesions.
  • Now the company wants to help spread information about how to protect yourself from monkeypox and STIs.
  • The most notable sign of monkeypox is a rash that is quite similar to common STIs like herpes or syphilis .
  • Today, the company offers over 50 at-home tests including COVID, sexual health, fertility, nutrition, allergies, hormone health, diabetes, toxicology, STDs and more.

Lucira Files for Authorization of First-of-its-Kind COVID-19 & Flu At-Home Molecular Test

Retrieved on: 
Thursday, May 12, 2022
Severe acute respiratory syndrome coronavirus 2, CEO, Private Securities Litigation Reform Act, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Food, CE marking, Electric Bond and Share Company v. Securities and Exchange Commission, EUA, Urinary tract infection, Jabil, Risk, STI, COVID-19, FDA, NAAT, Time, Clinical trial, Molisch's test, AA, Influenza, Forward-looking statement, PCR, Maintenance, Therapy, Sexually transmitted infection, Security (finance), Hand, Annual report, GLOBE, Pharmaceutical industry, Lucira

The Lucira COVID-19 & Flu test uses the same platform and palm-sized device design and independently tests for COVID-19, Flu A, and Flu B from a single nasal swab.

Key Points: 
  • The Lucira COVID-19 & Flu test uses the same platform and palm-sized device design and independently tests for COVID-19, Flu A, and Flu B from a single nasal swab.
  • Clinical trial results with the Lucira COVID-19 & Flu test were positive, demonstrating comparable sensitivity and specificity to leading lab-based PCR assays.
  • The Lucira COVID-19 & Flu test is a NAAT test utilizing the same platform and device design as Lucira's commercialized EUA authorized COVID-19 tests to provide independent diagnoses for COVID-19, Flu A, and Flu B.
  • Each Lucira test contains everything needed to run a single COVID-19 test: the test device, two AA batteries, sample vial, swab, and simple instructions.

Abbott Obtains FDA Clearance for First Test that Simultaneously Detects Four Common Sexually Transmitted Infections (STIs) as Cases are on the Rise

Retrieved on: 
Wednesday, May 4, 2022
Aline (song), COVID-19, Pandemic, Population, HIV, Incidence, Twitter, STI, Neisseria gonorrhoeae, Mycoplasma genitalium, Sexually transmitted infection, Human services, NYSE, Nutritional challenges of HIV/AIDS, Time, HBV, CDC, PCR, Patient, Projected, HIV-1, Becker, Infection, Polymerase chain reaction, Syphilis, Geography, STD, CT, FDA, Chlamydia trachomatis, Hepatitis, HCV, American Journal of Preventive Medicine, Hepatitis B, Center, Journal, Workflow, The Journal of Infectious Diseases, Severe acute respiratory syndrome coronavirus 2, Efficiency, Korea Disease Control and Prevention Agency, Gonorrhea, United States Department of Health and Human Services, Trichomonas vaginalis, LinkedIn, NG, Life, Technology, Emergency Use Authorization, Cancer, Mycoplasma, Risk, Birth control, Pharmaceutical industry, Vaccine, Chlamydia, Trichomonas

The test simultaneously detects and differentiates four common sexually transmitted infections (STIs).

Key Points: 
  • The test simultaneously detects and differentiates four common sexually transmitted infections (STIs).
  • The test runs on Abbott's Alinity m system the company's most advanced high-volume laboratory molecular instrument.
  • This test can help healthcare providers save time, increase efficiency and better serve patients.
  • CDC estimates 1 in 5 people in the U.S. have a sexually transmitted infection, https://www.cdc.gov/media/releases/2021/p0125-sexualy-transmitted-infect...
    5.

Spring Break Amidst Rising Reports of Sexually Transmitted Infections

Retrieved on: 
Monday, April 4, 2022
Sexually transmitted infection, Spring Breakers, Spring break, Attorney General Wells, Fertility, Syphilis, City, Health minister, CMO, Toxicology, STD, Gonorrhea, STI, Learning, Diabetes, Allergy, COVID, Awareness, Infection, Birth control, Lancet

LOS ANGELES, April 4, 2022 /PRNewswire/ -- Spring Break is upon us. Fortunately, myLAB Box is up to the challenge. Since 2013, myLAB Box has been leading the way in at-home testing-to-treatment options for Sexually Transmitted Infections (STIs) and beyond. According to a report from The Lancet, cases of sexually transmitted infections (STIs) are increasing worldwide. Even in the United States, local health boards in major cities are reporting marked increases in cases of gonorrhea and syphilis. myLAB Box offers a wide range of at-home testing options to help spring breakers detect STIs before and after their break.

Key Points: 
  • Since 2013, myLAB Box has been leading the way in at-home testing-to-treatment options for Sexually Transmitted Infections (STIs) and beyond.
  • According to a report from The Lancet , cases of sexually transmitted infections (STIs) are increasing worldwide.
  • myLAB Box offers a wide range of at-home testing options to help spring breakers detect STIs before and after their break.
  • "There is still a stigma attached to sexual health and sexually transmitted infections that prevents thousands of people from learning their status," said Miro.

Lupin Announces FDA Approval of Supplemental New Drug Application for SOLOSEC® (secnidazole) in Adolescents for both the Treatment of Bacterial Vaginosis in Females and Trichomoniasis

Retrieved on: 
Thursday, February 17, 2022
Energy drink, Woman, Propylene glycol, Prevalence, Abdominal pain, Regulation of food and dietary supplements by the U.S. Food and Drug Administration, Lupinus, Liver failure, Yogurt, Risk, Private Securities Litigation Reform Act, Gaps, Cockayne syndrome, Trichomoniasis, Health, New Drug Application, Vaginitis, Sex, Patient, Bacterial vaginosis, Shanda, Candidiasis, Diarrhea, Female, National Health and Nutrition Examination Survey, Vertically transmitted infection, BV, Patent, Ethanol, Lupin Limited, Sexually transmitted infection, Human, Metronidazole, Headache, Infection, CDC, Incidence, Vomiting, Vaginal yeast infection, National Health, Secnidazole, Reproductive health, Food, Environment, STI, FDA, Prescription, Nausea, Partner (business rank), Dysgeusia, Pharmaceutical industry, Birth control, Legume, Adolescence

"The FDA's approval expands the indication for SOLOSEC to treat adolescents and builds upon our commitment to support women's health.

Key Points: 
  • "The FDA's approval expands the indication for SOLOSEC to treat adolescents and builds upon our commitment to support women's health.
  • Vulvovaginal candidiasis may develop with SOLOSEC and require treatment with an antifungal agent.
  • To report SUSPECTED ADVERSE REACTIONS, contact Lupin Pharmaceuticals, Inc. at 1-844-SOLOSEC (1-844-765-6732) or FDA at 1-800-FDA-1088 or www.fda.gov/medwatch .
  • SOLOSEC is a registered trademark of Lupin Inc. and LUPIN is a registered trademark of Lupin Pharmaceuticals, Inc.

Africa Condom Market, Size, Forecasts Report 2022-2030: Industry Trends, Growth, Share, Impact of COVID-19, Opportunity Company Analysis - ResearchAndMarkets.com

Retrieved on: 
Wednesday, February 9, 2022
Medical Supplies, Health, People, Government, News, Industry, Sex education, Female, Awareness, CDC, UNAIDS, World, Internet, STI, STD, Condom, Center, Male, International, Sexual intercourse, Sex, Korea Disease Control and Prevention Agency, HIV disease progression rates, Pregnancy, Sexually transmitted infection, World Health Organization, WHO, Birth, COVID-19, Birth control, Growth

The "Africa Condom Market, Size, Forecast 2022-2030, Industry Trends, Growth, Share, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.

Key Points: 
  • The "Africa Condom Market, Size, Forecast 2022-2030, Industry Trends, Growth, Share, Impact of COVID-19, Opportunity Company Analysis" report has been added to ResearchAndMarkets.com's offering.
  • However the good news is that things are improving quickly, as UNAIDS, WHO, and many government agencies are raising awareness programs.
  • Due to these initiatives and awareness among the African population the use of condoms are rising year on year.
  • Based on Material, in this report the publisher has covered the condom market from 2 types of material Latex Condom Market and Non-Latex Condom Market.

binx health and Student Health Insurer, Wellfleet, Expand Agreement in College Health for In-Dorm and At-Home Access to Testing for Sexually Transmitted Infections (STIs)

Retrieved on: 
Wednesday, December 8, 2021
Professional Services, Education, Health, Infectious Diseases, Insurance, University, Biotechnology, COVID-19 testing, Binx, Risk, Gonorrhea, Company, Embarrassment, University, Population, Centers for Disease Control and Prevention, Health, Workplace, STI, Report, Center, Accident, Rachel Binx, CEO, Prevalence, COVID, STD, Cost, Chlamydia, Jean-Louis Vincent, Insurance, Multimedia, LLC, Korea Disease Control and Prevention Agency, COVID-19, Sexually transmitted infection, Superior, FDA, Infection, Berkshire Hathaway, Solution, Student, Medicine, Birth control, Pharmaceutical industry, Hospital

binx health, through an expanded agreement with student health insurer Wellfleet, will provide college students nationwide access to sexually transmitted infection (STI) testing.

Key Points: 
  • binx health, through an expanded agreement with student health insurer Wellfleet, will provide college students nationwide access to sexually transmitted infection (STI) testing.
  • View the full release here: https://www.businesswire.com/news/home/20211208005600/en/
    Enhancing access to STI testing is vital for the college population as college and university students are among the highest-risk populations for acquiring STIs.
  • Were hyper-focused on delivering a positive experience for our members through clinical programs designed to improve access to care.
  • Binx health is a healthcare technology and diagnostics company that makes routine testing convenient by enabling access to care where people live, work, study, and shop.

Medicines360 and the Population Council Pursue Agreement to Develop Product to Prevent HIV and Unintended Pregnancy for Worldwide Distribution

Retrieved on: 
Wednesday, December 1, 2021
Research, Patient, National Center for HIV/AIDS, Viral Hepatitis, STD, and TB Prevention, Birth, Regulation of tobacco by the U.S. Food and Drug Administration, Pre-exposure prophylaxis, Trustee, BMJ Sexual and Reproductive Health, Woman, Health, Population Council, Sexually transmitted infection, Prescription, SAN, Solution, Ageing, MPH, Reproductive health, Medical statistics, Condom, New Drug Application, Health minister, Pregnancy, Risk, National Center for Health Statistics, Population, China Tribunal, Infection, NDA, Council, Organization, United, FDA, DPP, Public health, NEW, Negotiation, Multimedia, MPT, Adolescence, PMID, Food, HIV, NCHS, Pharmaceutical industry, Birth control

The organizations are seeking philanthropic support for product development, and clinical and regulatory work to bring the product to market.

Key Points: 
  • The organizations are seeking philanthropic support for product development, and clinical and regulatory work to bring the product to market.
  • "This collaboration has the potential to be a ground-breaking innovation for women's health," said Tina Raine-Bennett, MD, MPH, Chief Executive Officer of Medicines360.
  • The DPP is designed for women of reproductive age who want to prevent pregnancy and are at high risk of contracting HIV.
  • Medicines360 is developing the DPP product and together with Population Council, plans to submit a New Drug Application (NDA) to the U.S. Food and Drug Administration (FDA).

InventHelp Inventor Develops Modified Condom for Added Protection (HLW-281)

Retrieved on: 
Tuesday, November 23, 2021
DEPT, Pregnancy, Sale, Ninth Street, Sexually transmitted infection, Vertically transmitted infection, Multimedia, Patent, Simplex, STD, Condom, Birth control

PITTSBURGH, Nov. 23, 2021 /PRNewswire/ --"I wanted to create an improved condom device to protect against STD's and pregnancy," said an inventor, from Hollywood, Fla., "so I invented the patent pending TESTICLE PROTECTION CONDOM.

Key Points: 
  • PITTSBURGH, Nov. 23, 2021 /PRNewswire/ --"I wanted to create an improved condom device to protect against STD's and pregnancy," said an inventor, from Hollywood, Fla., "so I invented the patent pending TESTICLE PROTECTION CONDOM.
  • As a result, it helps to protect against herpes, sexually-transmitted diseases and unwanted pregnancy and it provides added peace of mind.
  • The invention features a user-friendly design that is easy to use so it is ideal for sexually active individuals.
  • The original design was submitted to the Hollywood/Miami sales office of InventHelp.